NTRB
Nutriband IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$44.25M
P/E Ratio
—
EPS
$-2.58
Beta
1.96
52W High
$11.68
52W Low
$3.40
50-Day MA
$3.81
200-Day MA
$5.17
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
370.37
PEG Ratio
—
About Nutriband Inc
Nutriband Inc. develops a portfolio of transdermal pharmaceuticals. The company is headquartered in Orlando, Florida.
Fundamentals
| Revenue (TTM) | $2.04M |
| Gross Profit (TTM) | 566,310 |
| EBITDA | $-8.12M |
| Operating Margin | -254.80% |
| Return on Equity | -125.60% |
| Return on Assets | -69.20% |
| Revenue/Share (TTM) | $0.17 |
| Book Value | $0.55 |
| Price-to-Book | 6.63 |
| Price-to-Sales (TTM) | 21.73 |
| EV/Revenue | 19.6 |
| EV/EBITDA | -4.55 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -37.60% |
| Shares Outstanding | $12.16M |
| Float | $5.28M |
| % Insiders | 74.50% |
| % Institutions | 3.08% |
Historical Volatility
HV 10-Day
47.88%
HV 20-Day
57.04%
HV 30-Day
51.29%
HV 60-Day
53.82%
HV Rank
3.6%
Volatility is currently contracting
More HEALTHCARE Stocks
Data last updated: 5/25/2026